Related Experiment Video
Updated: Jan 21, 2026

The Extraction of Liver Glycogen Molecules for Glycogen Structure Determination
Published on: February 8, 2022
Glucose and glycogen in the diabetic kidney: Heroes or villains?
Mitchell A Sullivan1, Josephine M Forbes2
1Glycation and Diabetes Group, Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
Abstract:
Glucose metabolism in the kidney is currently foremost in the minds of nephrologists, diabetologists and researchers globally, as a result of the outstanding success of SGLT2 inhibitors in reducing renal and cardiovascular disease in individuals with diabetes. However, these exciting data have come with the puzzling but fascinating paradigm that many of the beneficial effects on the kidney and cardiovascular system seem to be independent of the systemic glucose lowering actions of these agents. This manuscript places into context an area of research highly relevant to renal glucose metabolism, that of glycogen accumulation and metabolism in the diabetic kidney. Whether the glycogen that abnormally accumulates is pathological (the villain), is somehow protective (the hero) or is inconsequential (the bystander) is a research question that may provide insight into the link between diabetes and diabetic kidney disease.
Insights
The role of kidney glycogen in diabetic kidney disease is explored. Understanding glycogen accumulation may reveal how diabetes damages kidneys, independent of blood sugar control.
Area of Science:
- Nephrology
- Diabetology
- Metabolic Research
Background:
- Sodium-glucose cotransporter 2 (SGLT2) inhibitors show significant renal and cardiovascular benefits in diabetic patients.
- These benefits appear to be partly independent of systemic glucose-lowering effects, prompting research into alternative mechanisms.
Purpose of the Study:
- To investigate the role of glycogen accumulation and metabolism in the diabetic kidney.
- To determine if renal glycogen is pathological, protective, or inconsequential in the context of diabetic kidney disease.
Main Methods:
- Review of current literature on renal glucose metabolism and SGLT2 inhibitor mechanisms.
- Analysis of studies investigating glycogen deposition in the diabetic kidney.
Main Results:
- Abnormal glycogen accumulation occurs in the diabetic kidney.
- The precise role of this glycogen (pathological, protective, or bystander) remains unclear.
Conclusions:
- Investigating renal glycogen metabolism is crucial for understanding diabetic kidney disease.
- This research may elucidate mechanisms linking diabetes to kidney complications beyond glycemic control.
Related Concept Videos
Kidney Structure
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

